RxDoctor Payments Data

Michael Slutzker, MD

Orthopaedic Surgery · Torrance, CANPI 1306996186

Payments from drug & device makers

$2,912in general payments, 2019–2025

Across 41 payments — averaging $71.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Orthopedics Inc$2K
  • Amgen$271
  • Stryker$167
  • Smith+Nephew$140
  • Dynasplint Systems Inc.$82
  • ERMI LLC$80
  • plus $143 from 4 others

What the payments were for

  • Travel & lodging$88830%
  • Food & beverage$2,02570%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Microport Orthopedics Inc14$2,030
Amgen16$271
Stryker1$167
Smith+Nephew1$140
Dynasplint Systems Inc.1$82
ERMI LLC2$80
Pacira Pharmaceuticals Incorporated2$58
Bioventus LLC2$51
AbbVie1$20
Johnson & Johnson1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,912 in reported general payments places this provider in the 50th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$170,474
Medicare patients
199
Services billed
5,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium82$9,593
Celecoxib57$5,820
Methylprednisolone103$506
Naproxen69$321
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$272
Ibuprofen33$202
Meloxicam114$194
Gabapentin31$194
Cyclobenzaprine Hcl17$69

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →